Bedrosian Camille L
Rhythm Pharmaceuticals, Inc. · Director
Bedrosian Camille L is listed in filings as Director at Rhythm Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including sale activity. Recent filings connect the profile to Rhythm Pharmaceuticals, Inc. (RYTM), Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX), and Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Oct 2, 2024 to Mar 9, 2026. Reported amounts are shown as $448.0K to $36.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $37k11.4k shares | SellSep 30, 2024 | $3.20 | $17.02 | |
| $30k5.4k shares | SellDec 2, 2024 | $5.54 | $17.02 | |
| $43k12.4k shares | SellMar 31, 2025 | $3.47 | $17.02 | |
| $176k12k shares | SellSep 30, 2025 | $14.58 | $17.02 | |
| $94k6.6k shares | SellDec 1, 2025 | $14.35 | $17.02 |